Smith Alicia K, Meyers Deborah A
Centers for Disease Control and Prevention, Atlanta, GA, USA.
Immunol Allergy Clin North Am. 2005 Nov;25(4):641-54. doi: 10.1016/j.iac.2005.09.003.
Although it is not yet known how many genes may contribute to the susceptibility or the severity of asthma and related phenotypes, genome-wide screens and positional cloning techniques have been successful in identifying contributing genes in multiple populations. The results of these studies provide additional insight into the molecular mechanisms responsible for the development of a variety of phenotypes. Replication with additional populations--particularly in large-scale studies--has been used to distinguish between false positive results or population-specific effects or to further quantify the conferred risk. Even when individual markers do not replicate in multiple population, association of the same region or gene has been useful in directing future studies. As further understanding of linkage disequilibrium patterns within the genome has allowed greater efficiency for genetic studies, advances in high-throughput genotyping technology, genetic analysis methodologies, and a more in-depth understanding of clinical phenotypes has made genome-wide studies more accessible and cost-effective. In the future, identification of function variants with clinical relevance may be used to influence the diagnosis and treatment of asthma.
尽管目前尚不清楚有多少基因可能导致哮喘及相关表型的易感性或严重程度,但全基因组筛查和定位克隆技术已成功在多个群体中鉴定出相关基因。这些研究结果为导致各种表型发展的分子机制提供了更多见解。在其他群体中进行重复研究——尤其是在大规模研究中——已被用于区分假阳性结果或群体特异性效应,或进一步量化所赋予的风险。即使个别标记在多个群体中无法重复,但同一区域或基因的关联在指导未来研究方面也很有用。随着对基因组内连锁不平衡模式的进一步了解提高了基因研究的效率,高通量基因分型技术、遗传分析方法的进步以及对临床表型更深入的理解,使得全基因组研究更容易进行且更具成本效益。未来,鉴定具有临床相关性的功能变异可能会用于影响哮喘的诊断和治疗。